238 related articles for article (PubMed ID: 2521388)
21. Immunocytological and immunochemical analysis on the common acute lymphoblastic leukemia antigen (CALLA): evidence that CALLA on ALL cells and granulocytes are structurally related.
Fujimoto J; Ishimoto K; Kiyokawa N; Tanaka S; Ishii E; Hata J
Hybridoma; 1988 Jun; 7(3):227-36. PubMed ID: 2969365
[TBL] [Abstract][Full Text] [Related]
22. [Characterization of murine monoclonal antibodies against the common acute leukemia antigen (CALLA)].
Seifert M; Eichler W; Fiebig H
Allerg Immunol (Leipz); 1990; 36(4):267-76. PubMed ID: 2151502
[TBL] [Abstract][Full Text] [Related]
23. Significance of common acute lymphoblastic leukemia antigen (cALLA) positive cells in bone marrow of children off therapy in complete remission.
Self SE; Morgan S; Grush O; La Via MF
Hematol Oncol; 1990; 8(2):91-5. PubMed ID: 2140561
[TBL] [Abstract][Full Text] [Related]
24. Murine common acute lymphoblastic leukemia antigen (CD10 neutral endopeptidase 24.11). Molecular characterization, chromosomal localization, and modeling of the active site.
Chen CY; Salles G; Seldin MF; Kister AE; Reinherz EL; Shipp MA
J Immunol; 1992 May; 148(9):2817-25. PubMed ID: 1374101
[TBL] [Abstract][Full Text] [Related]
25. Modulation of CALLA (CD10) antigen on cultured ALL (REH) cells: effect of various modulators.
Chorváth B; Sedlák J; Duraj J; Plesková I; Dubovský P; Augustinová M; Doxiadis I; Grosse-Wilde H
Neoplasma; 1990; 37(6):609-18. PubMed ID: 2148811
[TBL] [Abstract][Full Text] [Related]
26. Expression of the common acute lymphoblastic leukemia antigen (CALLA) on the surface of individual cells of human lymphoblastoid lines.
Goldmacher VS; Lambert JM; Young AY; Anderson J; Tinnel NL; Kornacki M; Ritz J; Blättler WA
J Immunol; 1986 Jan; 136(1):320-5. PubMed ID: 2415623
[TBL] [Abstract][Full Text] [Related]
27. Elevated synovial tissue concentration of the common acute lymphoblastic leukaemia antigen (CALLA)-associated neutral endopeptidase (3.4.24.11) in human chronic arthritis.
Sreedharan SP; Goetzl EJ; Malfroy B
Immunology; 1990 Sep; 71(1):142-4. PubMed ID: 2145213
[TBL] [Abstract][Full Text] [Related]
28. Quantitative variation of the common acute lymphoblastic leukemia antigen (gp100) on leukemic marrow blasts.
Look AT; Melvin SL; Brown LK; Dockter ME; Roberson PK; Murphy SB
J Clin Invest; 1984 Jun; 73(6):1617-28. PubMed ID: 6233301
[TBL] [Abstract][Full Text] [Related]
29. Detection of the common acute lymphoblastic leukemia antigen in the serum of leukemia patients.
Carrel S; Buchegger F; Heumann D; Girardet C; Barras C; Losa G; Mach JP; von Fliedner V
J Clin Invest; 1984 Nov; 74(5):1882-5. PubMed ID: 6334103
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of enkephalin-mediated inflammatory responses by CD10/neutral endopeptidase 24.11.
Shipp MA; Stefano GB; D'Adamio L; Switzer SN; Howard FD; Sinisterra J; Scharrer B; Reinherz EL
Nature; 1990 Sep; 347(6291):394-6. PubMed ID: 1699130
[TBL] [Abstract][Full Text] [Related]
31. Common acute lymphoblastic leukemia-associated antigen (CALLA)-positive B cell lymphoma.
Abe M; Nozawa Y; Wachi E; Wakasa H
Acta Pathol Jpn; 1989 Aug; 39(8):503-8. PubMed ID: 2530751
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
33. [Neutral endopeptidase activity in human peripheral blood leukocytes].
Kimura A; Iwamoto I; Ochiai K; Nakagawa N; Tomioka H; Yoshida S
Arerugi; 1990 Mar; 39(3):307-12. PubMed ID: 2375683
[TBL] [Abstract][Full Text] [Related]
34. Structure/function studies of the common acute lymphoblastic leukemia antigen (CALLA/CD10) expressed on human neutrophils.
McCormack RT; Nelson RD; LeBien TW
J Immunol; 1986 Aug; 137(3):1075-82. PubMed ID: 2941484
[TBL] [Abstract][Full Text] [Related]
35. Expression of the common acute lymphoblastic leukaemia antigen (CALLA) in the human breast.
Mahendran R; McIlhinney R; O'Hare M; Monaghan P; Gusterson B
Mol Cell Probes; 1989 Mar; 3(1):39-44. PubMed ID: 2525226
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas.
Dragović T; Deddish PA; Tan F; Weber G; Erdös EG
Lab Invest; 1994 Jan; 70(1):107-13. PubMed ID: 8302012
[TBL] [Abstract][Full Text] [Related]
37. Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens.
Ryan D; Kossover S; Mitchell S; Frantz C; Hennessy L; Cohen H
Blood; 1986 Aug; 68(2):417-25. PubMed ID: 2942198
[TBL] [Abstract][Full Text] [Related]
38. The non immunogenicity of CALLA in leukemic children.
Komada Y; Yamamoto H; Azuma E; Tanaka S; Kamiya H; Sakurai M
Biomed Pharmacother; 1988; 42(10):669-73. PubMed ID: 2976604
[TBL] [Abstract][Full Text] [Related]
39. Distribution of neutral endopeptidase activity in human blood leukocytes.
Iwamoto I; Kimura A; Ochiai K; Tomioka H; Yoshida S
J Leukoc Biol; 1991 Feb; 49(2):116-25. PubMed ID: 1991995
[TBL] [Abstract][Full Text] [Related]
40. Thiorphan, an inhibitor of neutral endopeptidase/enkephalinase (CD10/CALLA) enhances cell proliferation in bone marrow cultures of patients with acute leukemia in remission.
Stanović S; Boranić M; Petrovecki M; Batinić D; Skodlar J; Nemet D; Labar B
Haematologia (Budap); 2000; 30(1):1-10. PubMed ID: 10841318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
